| Year |
Citation |
Score |
| 2013 |
Karagiannis ED, Urbanska AM, Sahay G, Pelet JM, Jhunjhunwala S, Langer R, Anderson DG. Rational design of a biomimetic cell penetrating peptide library. Acs Nano. 7: 8616-26. PMID 24047542 DOI: 10.1021/Nn4027382 |
0.506 |
|
| 2012 |
Karagiannis ED, Alabi CA, Anderson DG. Rationally designed tumor-penetrating nanocomplexes. Acs Nano. 6: 8484-7. PMID 23088785 DOI: 10.1021/Nn304707B |
0.449 |
|
| 2010 |
Koskimaki JE, Karagiannis ED, Tang BC, Hammers H, Watkins DN, Pili R, Popel AS. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. Bmc Cancer. 10: 29. PMID 20122172 DOI: 10.1186/1471-2407-10-29 |
0.699 |
|
| 2009 |
Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT, Raman V, Bhujwalla ZM, Popel AS. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (New York, N.Y.). 11: 1285-91. PMID 20019836 DOI: 10.1593/Neo.09620 |
0.704 |
|
| 2009 |
Qutub AA, Mac Gabhann F, Karagiannis ED, Vempati P, Popel AS. Multiscale models of angiogenesis. Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society. 28: 14-31. PMID 19349248 DOI: 10.1109/Memb.2009.931791 |
0.649 |
|
| 2009 |
Cano Mdel V, Karagiannis ED, Soliman M, Bakir B, Zhuang W, Popel AS, Gehlbach PL. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization. Investigative Ophthalmology & Visual Science. 50: 3840-5. PMID 19279315 DOI: 10.1167/Iovs.08-2607 |
0.63 |
|
| 2008 |
Karagiannis ED, Popel AS. A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 13775-80. PMID 18780781 DOI: 10.1073/Pnas.0803241105 |
0.651 |
|
| 2008 |
Karagiannis ED, Popel AS. Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines. Journal of Cellular Biochemistry. 104: 1356-63. PMID 18307172 DOI: 10.1002/Jcb.21712 |
0.663 |
|
| 2007 |
Vempati P, Karagiannis ED, Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. The Journal of Biological Chemistry. 282: 37585-96. PMID 17848556 DOI: 10.1074/Jbc.M611500200 |
0.501 |
|
| 2007 |
Karagiannis ED, Popel AS. Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells. The International Journal of Biochemistry & Cell Biology. 39: 2314-23. PMID 17707681 DOI: 10.1016/J.Biocel.2007.06.018 |
0.666 |
|
| 2007 |
Karagiannis ED, Popel AS. Anti-angiogenic peptides identified in thrombospondin type I domains. Biochemical and Biophysical Research Communications. 359: 63-9. PMID 17531201 DOI: 10.1016/J.Bbrc.2007.05.041 |
0.652 |
|
| 2007 |
Karagiannis ED, Popel AS. Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties. Biochemical and Biophysical Research Communications. 354: 434-9. PMID 17239819 DOI: 10.1016/J.Bbrc.2006.12.231 |
0.581 |
|
| 2006 |
Karagiannis ED, Popel AS. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. Journal of Theoretical Biology. 238: 124-45. PMID 16005020 DOI: 10.1016/J.Jtbi.2005.05.020 |
0.535 |
|
| 2004 |
Karagiannis ED, Popel AS. A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. The Journal of Biological Chemistry. 279: 39105-14. PMID 15252025 DOI: 10.1074/Jbc.M403627200 |
0.5 |
|
| Show low-probability matches. |